|
|
|
|
Timolol is well-tolerated for further pressure control in glaucoma
San Francisco?Timolol maleate 0.5%/sorbitol complex (Istalol, ISTA Pharmaceuticals) is a convenient, effective, and well-tolerated choice for adjunctive therapy in patients taking a prostaglandin analogue who need further IOP control, according to the...
|
|
|
Ista reports 33% increase in net revenue for financial year 2009
Submit a Comment IRVINE, Calif.- Ista Pharmaceuticals reported a 33% increase in net revenue for its 2009 financial year compared with the previous year, the company announced in a press release. Year-end net revenue totaled $110.6 million. In addition,...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
IRVINE, Calif., Feb.23 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today reported financial results for the quarter and the year ended December 31, 2009. Fourth quarter 2009 net revenue of $34.3 million increased 22% from the...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
IRVINE, Calif., Feb.23 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today reported financial results for the quarter and the year ended December 31, 2009. Fourth quarter 2009 net revenue of $34.3 million increased 22% from the...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
IRVINE, Calif., Feb.23 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today reported financial results for the quarter and the year ended December 31, 2009. Fourth quarter 2009 net revenue of $34.3 million increased 22% from the...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
2009 Revenue Increases 33% to $110.6 Million - - Company Exceeds Guidance and Reports Operating Income of $2.1 Million - - Company Generates Positive Cash Flow of $2.7 Million in 2009 - - Company Expects to Become Profitable in 2010 (excluding warrant charges) ...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
IRVINE, Calif., Feb.23 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (ISTA), today reported financial results for the quarter and the year ended December 31, 2009. long_spaceFourth quarter 2009 net revenue of $34.3 million increased 22% from the...
|
|
|
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2009 Financial Results
Companies: Related QuotesSymbolPriceChangeISTA4.14-0.01{'s' : 'ista','k' : 'c10,l10,p20,t10','o' : '','j' : ''} Press Release Source: ISTA Pharmaceuticals, Inc.On Tuesday February 23, 2010, 4:00 pm IRVINE, Calif. 'The solid financial performance we...
|
|
|
::: ISTA Pharmaceuticals Announces 2010 Financial Guidance
ISTA Expects 2010 Net Revenue of $147 to $165 Million Company Anticipates 2010 Operating Income of $8 to $10 Million IRVINE, Calif., Feb.9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) today announced financial guidance for the full...
|
|
|
ISTA Pharmaceuticals Announces 2010 Financial Guidance
ISTA Expects 2010 Net Revenue of $147 to $165 Million Company Anticipates 2010 Operating Income of $8 to $10 Million IRVINE, Calif., Feb.9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) today announced financial guidance for the full...
|
|
|
ISTA Pharmaceuticals Announces 2010 Financial Guidance
IRVINE, Calif., Feb.9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced financial guidance for the full year 2010. The Company expects net revenue will be approximately $147 to $165 million. In addition, ISTA's...
|
|
|
ISTA Pharmaceuticals Announces 2010 Financial Guidance
IRVINE, Calif., Feb.9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced financial guidance for the full year 2010. The Company expects net revenue will be approximately $147 to $165 million. In addition, ISTA's...
|
|
|
ISTA Pharmaceuticals Announces 2010 Financial Guidance
ISTA Expects 2010 Net Revenue of $147 to $165 Million Company Anticipates 2010 Operating Income of $8 to $10 Million PR Newswire IRVINE, Calif., Feb.9 IRVINE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today...
|
|
|
ISTA Pharmaceuticals Announces 2010 Financial Guidance
ISTA Expects 2010 Net Revenue of $147 to $165 Million Company Anticipates 2010 Operating Income of $8 to $10 Million PR Newswire IRVINE, Calif., Feb.9 IRVINE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today...
|
|
|
ISTA Pharmaceuticals Announces 2010 Financial Guidance
ISTA Expects 2010 Net Revenue of $147 to $165 Million Company Anticipates 2010 Operating Income of $8 to $10 Million PR Newswire IRVINE, Calif., Feb.9 IRVINE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today...
|
|
|
ISTA Pharmaceuticals Announces 2010 Financial Guidance
ISTA Expects 2010 Net Revenue of $147 to $165 Million Company Anticipates 2010 Operating Income of $8 to $10 Million PR Newswire IRVINE, Calif., Feb.9 IRVINE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today...
|
